S182: TALQUETAMAB, A G PROTEIN‐COUPLED RECEPTOR FAMILY C GROUP 5 MEMBER D X CD3 BISPECIFIC ANTIBODY, IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED EFFICACY AND SAFETY RESULTS FROM MONUMENTAL‐1
Minnema, M. C., Krishnan, A., Berdeja, J. G., Oriol, A., Donk, N. W., Rodríguez‐Otero, P., Morillo, D., Mateos, M.‐V., Costa, L. J., Caers, J., Vishwamitra, D., Ma, J., Yang, S., Hilder, B. W., Tolbert, J., Goldberg, J. D., Chari, A.
Published in HemaSphere (01.06.2022)
Published in HemaSphere (01.06.2022)
Get full text
Journal Article
P10: TALQUETAMAB, A G PROTEIN‐COUPLED RECEPTOR FAMILY C GROUP 5 MEMBER D X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED PHASE 1 RESULTS FROM MONUMENTAL‐1
Donk, N. W. C. J, Minnema, M C, Berdeja, J G, Oriol, A, Krishnan, A, Rodríguez‐Otero, P, Askari, E, Mateos, M, Costa, L. J, Verona, R, Ma, J, Girgis, S, Yang, S, Hilder, B. W, Russell, J, Goldberg, J. D, Chari, A
Published in HemaSphere (01.04.2022)
Published in HemaSphere (01.04.2022)
Get full text
Journal Article
A Phase 1 and 2 study of Filanesib alone and in combination with low‐dose dexamethasone in relapsed/refractory multiple myeloma
Shah, Jatin J., Kaufman, Jonathan L., Zonder, Jeffrey A., Cohen, Adam D., Bensinger, William I., Hilder, Brandi W., Rush, Selena A., Walker, Duncan H., Tunquist, Brian J., Litwiler, Kevin S., Ptaszynski, Mieke, Orlowski, Robert Z., Lonial, Sagar
Published in Cancer (01.12.2017)
Published in Cancer (01.12.2017)
Get full text
Journal Article